BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 30, 2026
Home
»
Topics
»
Disease categories and therapies
» Substance use and poisoning
Substance use and poisoning
RSS
Fennec launches European Named Patient Program for sodium thiosulfate
May 31, 2017
Selecta initiates phase I trial of nicotine vaccine candidate SELA-070
May 15, 2017
Embera NeuroTherapeutics' EMB-001 well tolerated in phase Ib cocaine interaction study
May 9, 2017
Cleveland BioLabs updates entolimod progress
April 18, 2017
Battelle and Nanotherapeutics form alliance on medical countermeasures
April 6, 2017
SRI International receives FDA clearance to evaluate novel oral formulation of Zn-DTPA
April 3, 2017
BARDA elects not to exercise options for AEOL-10150 development for ARS and DEARE
March 28, 2017
Opiant receives FDA feedback on development of OPNT-002 for alcohol use disorder
March 2, 2017
Aeolus Pharmaceuticals starts phase I study of new formulation of AEOL-10150
Feb. 23, 2017
FDA issues complete response letter for Amphastar's intranasal naloxone
Feb. 23, 2017
Previous
1
2
…
25
26
27
28
29
30
31
32
33
…
119
120
Next
RSS